Conditions: Schizophrenia
Keywords: Schizophrenia
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 106
Healthy volunteers: no

Brief summary:
This study is designed to assess the effects of AZD 2624 in patients with schizophrenia

Detailed description:

Arms:
arm 1: AZD2624 40 mg arm 2: Olanzapine 15 mg arm 3: Matching Placebo

Interventions: intervention 1: AZD2624 intervention 2: Olanzapine intervention 3: Placebo
Intervention descriptions: intervention 1: Oral Suspension intervention 2: PO BID intervention 3: None

Protocol document: